CXCL8 and Hypercholesterolemia: Furthermore, in vitro and in vivo experimental studies using simvastatin have shown reduction in the expression of proinflammatory cytokines, such as MCP-1, IL-6, and IL-8, in patients with hypercholesterolemia [28].